新型冠狀病毒

Oxford/AstraZeneca vaccine to be approved by UK within days

Jab seen as critical to government’s target of reaching the most vulnerable parts of the population

The UK will approve the Oxford university/AstraZeneca coronavirus vaccine in the coming days, with the number of people being vaccinated expected to increase significantly from the first week of January.

The Oxford/AstraZeneca vaccine is seen as game-changing within Whitehall, as its cheapness and ease of storage will allow the government to vaccinate more quickly. The BioNTech/Pfizer vaccine, which was approved earlier this month, must be kept at minus 70C and can be moved only four times within a cold chain before being used.

More than 600,000 people have already been vaccinated in the UK, according to data released on Thursday. But the approval of the second vaccine is critical for meeting the government’s target of vaccinating the most vulnerable parts of the population by spring.

您已閱讀22%(793字),剩餘78%(2853字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×